PRAX - Company ID 0001689548
The table below shows Praxis Precision Medicines, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $8.55M | $2.45M | $0.00 | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $267.12M | $152.41M | $86.77M | $155.04M | $120.26M | $44.98M |
| SG&A |
Praxis Precision Medicines, Inc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $8.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $59.08M |
| $56.30M |
| $42.05M |
| $59.95M |
| $47.08M |
| $16.99M |
| Operating income | -$326.20M | -$200.16M | -$126.37M | -$214.99M | -$167.33M | -$61.97M |
| Income tax | $471.00K | - | - | - | $0.00 | -$8.00K |
| Net income | -$303.00M | -$183.00M | -$123.00M | -$214.00M | -$167.00M | -$61.82M |
| EPS (diluted) | -$13.48 | -$10.21 | -$18.69 | -$69.65 | -$3.94 | -$7.86 |